Literature DB >> 32224296

Tracking COVID-19 responsibly.

Rania Muhareb1, Rita Giacaman2.   

Abstract

Entities:  

Year:  2020        PMID: 32224296      PMCID: PMC7194718          DOI: 10.1016/S0140-6736(20)30693-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
As of March 25, 2020, WHO's online coronavirus disease 2019 (COVID-19) situation dashboard reveals that the pandemic spans 195 countries and territories with 375 498 cases. With this rapid expansion of the pandemic comes a growing need to ensure that accurate and credible information is accessible to public health authorities, researchers, and the wider public. This has prompted WHO, institutions, and individuals to develop online tools to track the spread of the pandemic. Although WHO's emergency preparedness is informed by established principles of international law, the multiplicity of actors has the potential to create confusion and barriers to accessing reliable and consistent data. These actors’ categorisation of countries and territories, which could be subject to geopolitical considerations, remains unaccountable to affected populations. One of the most visible tools to track COVID-19 has been the online dashboard hosted by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. Using data from WHO and health departments, among others, the CSSE dashboard has recorded COVID-19 cases, deaths, and recoveries worldwide since Jan 22, 2020. Although effective in tracking the pandemic in real time, the dashboard has proven ambiguous in its country designations, particularly with respect to the occupied Palestinian territory (oPt). Since March 5, 2020, when COVID-19 cases were first confirmed in Bethlehem, the number of cases in the West Bank has risen to 60, whereas two cases have been recorded in the Gaza Strip, and Israel has confirmed 2170 cases by March 25, 2020. Initially listing data recorded by the Palestinian Health Ministry in the West Bank and the Gaza Strip under its entry for Palestine, the dashboard separately listed cases confirmed by the Israeli Health Ministry. On March 10, CSSE replaced the entry for Palestine with oPt; on March 11, the oPt entry was removed and its figures merged with the entry for Israel. International law does not recognise Israeli sovereignty over any part of the oPt,3, 4 and the Israeli Health Ministry does not record COVID-19 cases in the West Bank and the Gaza Strip. How, then, can we effectively monitor the spread of the pandemic in the oPt using the CSSE dashboard? Of all times, now is exactly when the international medical and public health community must cooperate to provide accurate, impartial, and sufficiently detailed information on the spread of COVID-19, to inform containment measures and public health research. The removal of the oPt from the CSSE dashboard goes against global scientific cooperation and solidarity, resulting in discrepancies with official data recorded by the Palestinian and Israeli Health Ministries. Consistency with international law and the need for impartial data on the spread of COVID-19 requires databases to list the oPt separately, as reflected in WHO practice. Instead, removing the oPt and merging it with Israel undermines the credibility of the CSSE dashboard. All the more concerning is the dashboard's use of US State Department country designations, which have legitimised the acquisition of territory by force and undermined Palestinian identity and rights in Jerusalem. It is regrettable that Johns Hopkins University, an institution with historic ties to the slave trade, should continue its colonial violence against the indigenous Palestinian people by removing Palestine from the world map. In the same way that Johns Hopkins University has started acknowledging the indigenous Piscataway people, the traditional owners of the lands upon which the university is built, Johns Hopkins University must also recognise symbolic violence and ensure that it does not contribute to the erasure of indigenous peoples across the globe. As countries around the world fight to contain the spread of COVID-19, it is more critical than ever to guarantee the ethical integrity and impartiality of scientific research and to ensure the delivery of accurate, reliable, and representative information to affected communities worldwide. We have contacted CSSE twice on this matter since March 15, 2020, and have not received a response as of March 25, 2020. For the University of Virginia's COVID-19 surveillance dashboard see http://nssac.bii.virginia.edu/covid-19/dashboard/ For the University of Washington's COVID-19 infection map see https://hgis.uw.edu/virus/ For the European Centre for Disease Prevention and Control's COVID-19 situation update see https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases For Avi Schiffmann's dashboard see https://ncov2019.live/data
  6 in total

1.  Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron.

Authors:  Rui Dong; Taojun Hu; Yunjun Zhang; Yang Li; Xiao-Hua Zhou
Journal:  Vaccines (Basel)       Date:  2022-03-24

2.  Applications, features and key indicators for the development of Covid-19 dashboards: A systematic review study.

Authors:  Akram Vahedi; Hamid Moghaddasi; Farkhondeh Asadi; Azam Sadat Hosseini; Eslam Nazemi
Journal:  Inform Med Unlocked       Date:  2022-03-18

3.  Understanding the spatial diffusion dynamics of the COVID-19 pandemic in the city system in China.

Authors:  Lijuan Gu; Linsheng Yang; Li Wang; Yanan Guo; Binggan Wei; Hairong Li
Journal:  Soc Sci Med       Date:  2022-04-28       Impact factor: 5.379

4.  GIS-based COVID-19 vulnerability mapping in the West Bank, Palestine.

Authors:  Sameer Shadeed; Sandy Alawna
Journal:  Int J Disaster Risk Reduct       Date:  2021-07-22       Impact factor: 4.320

5.  Pandemicity, COVID-19 and the limits of public health 'science'.

Authors:  Eugene T Richardson
Journal:  BMJ Glob Health       Date:  2020-04-17

6.  Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study.

Authors:  Xisheng Yan; Fen Li; Xiao Wang; Jie Yan; Fen Zhu; Shifan Tang; Yingzhong Deng; Hua Wang; Rui Chen; Zhili Yu; Yaping Li; Jingzhou Shang; Lingjun Zeng; Jie Zhao; Chaokun Guan; Qiaomei Liu; Haifeng Chen; Wei Gong; Xin Huang; Yu-Jiao Zhang; Jianguang Liu; Xiaoyan Dong; Wen Zheng; Shaoping Nie; Dongsheng Li
Journal:  J Med Virol       Date:  2020-06-09       Impact factor: 20.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.